Germ cell tumors (GCTs) are unique in that they exhibit diverse biological characteristics and pathological features. Although several in vivo GCT models are available, studies on GCTs are hampered because in vivo development of GCTs is time consuming and prevents a detailed molecular analysis of the transformation process. Here we developed a novel strategy to transform mouse testis cells in vitro. Lentivirus-mediated transfection of dominant negative Trp53, Myc, and activated Hras1 into a CD9-expressing testis cells caused tumorigenic conversion in vitro. Although these cells resembled embryonic stem (ES) cells, they were aneuploid and lacked Nanog expression, which is involved in the maintenance of the undifferentiated state in ES cells. Euploid ES-like cells were produced by transfecting the Yamanaka factors (Pou5f1, Myc, Klf4, and Sox2) into the same cell population. Although these cells expressed Nanog, they were distinct from ES cells in that they expressed CD44, a cancer stem cell antigen. Both treatments induced similar changes in the DNA methylation patterns in differentially methylated regions of imprinted genes. Moreover, despite the differences in their phenotype and karyotype, both cell types similarly produced mixed GCTs on transplantation, which were composed of teratomas, seminomas, and embryonal carcinomas. Thus, in vitro testis cell transformation facilitates an analysis of the GCT formation process, and our results also suggest the close similarity between GCT formation and reprogramming.
INTRODUCTION
Germ cell tumors (GCTs) are one of the most frequent tumors in adult males and are unique among solid tumors in that they exhibit a variety of morphological and biological properties [1, 2] . To date, analyses of GCT formation have depended on in vivo animal models. In classic experiments, ectopically transplanted fetal genital ridges produced teratomas in 129 mice [3] . More recently, in vivo transgenic overexpression of glial cell line-derived neurotrophic factor (Gdnf), a selfrenewal factor for spermatogonial stem cells (SSCs), caused seminomatous tumors [4] . Although the efficiency of tumor formation is relatively high (;80% in teratoma and ;90% in seminoma studies, respectively), in vivo tumor development prevents detailed analyses of transforming mechanisms and takes at least several weeks to 1 yr. Moreover, difficulties in transfecting germ cells and lack of culture systems also limit molecular-level analyses.
SSCs provide the foundation for spermatogenesis, which continues throughout the life of male animals [5, 6] . Although there are few SSCs and they proliferate slowly in vivo, these cells can be expanded in vitro by GDNF stimulation. Cultured SSCs, designated as germline stem (GS) cells, proliferate for more than 2 yr and are amenable to genetic manipulations [7] . Using GS cells, we recently found that GDNF drives SSC selfrenewal via activation of the Hras1-Ccnd2 pathway [8] . Our analysis showed that SRC family molecules induce Hras1 activation in response to GDNF treatment and that Ccnd2 and Ccne1 are subsequently upregulated by activated Hras1 (Hras1V12; R). GS cells transfected with the R gene (Ras-GS cells) or cotransfected with Ccnd2 and Ccne1 genes not only proliferate under cytokine-free conditions in vitro but also produce seminomatous tumors after transplantation into seminiferous tubules [8] .
While these results suggest a link between excess SSC selfrenewal and GCT formation, analysis of the transforming process is complicated because the seminomatous tumors from GS cells were found 3 mo after transplantation and developed only in vivo, suggesting that additional mutations occurred during long-term proliferation in the seminiferous tubules. In this study, we established a novel method for in vitro testis cell transformation. This method allowed for a transformation within ;2 wk and transformed cells produced mixed GCTs after transplantation.
MATERIALS AND METHODS

Cell Culture
GS cells and multipotent germline stem (mGS) cells used in this study were described previously [7, 9] . The growth factors used were 10 ng/ml human FGF2 and 15 ng/ml rat GDNF (both from Peprotech, Rocky Hill, NJ). Cells were maintained on mitomycin C-treated mouse embryonic fibroblasts (MEFs).
We used 7-to 10-day-old ICR mice for the primary spermatogonial culture (Japan SLC, Shizuoka, Japan). In experiments to determine the target cells, we used 7-to 10-day-old WBB6F1 wild-type (WT) or W/W v (W) mice. Induced pluripotent stem (iPS) cells were produced by collecting MEFs from ICR male embryos 13.5 days postcoitum after removing genital ridges. Testis cells were dissociated by two-step enzymatic digestion using collagenase type IV (Sigma, St. Louis, MO) and trypsin (Nacalai Tesque, Kyoto, Japan) as described previously [10] . The dissociated cells were incubated with biotin-conjugated rat anti-mouse CD9 antibody (KMC8; BD Biosciences, Franklin Lakes, NJ). In experiments to determine the target cell population, we also used rat anti-mouse EPCAM antibody (G8.8; BioLegend, San Diego, CA). Magnet cell sorting (MACS) was then performed using Dynabeads following the manufacturer's instruction, as described previously (Invitrogen, Carlsbad, CA) [11] . Both GS cells and primary testis cells were initially maintained in StemPro-34 SFM (Invitrogen) but were subsequently maintained on MEFs in Dubelco modified Eagle medium supplemented with leukemia inhibitory factor (ESGRO; Invitrogen) and 15% fetal bovine serum approximately 2 wk after transfection.
Cell adhesion properties were determined by plating aliquots of 1 3 10 5 cells in a 12-well plate coated with gelatin (0.2%; Nacalai Tesque) or laminin (20 lg/ml; BD Biosciences). Two days after plating, the plates were washed with phosphate-buffered saline, and the cells were recovered by treatment with 0.25% trypsin. Anchorage independent growth of transformed cells was examined by suspending 2 3 10 5 cells in 1 ml of methylcellulose (R&D Systems, Minneapolis, MN), followed by culture in a 24-well plate.
Apoptosis Assay
A single cell suspension was concentrated on glass slides by centrifugation with Cytospin 4 (Thermo Electron Corporation, Cheshire, U.K.) for TUNEL staining. After fixing the cells in 4% paraformaldehyde for 1 h, they were labeled using a TMR red In situ Cell Death Detection kit (Roche Applied Science, Mannheim, Germany) following the manufacturer's protocol. The cells were counterstained with Hoechst 33342 (2 lg/ml; Sigma) to determine the percentage of TUNEL-positive nuclei relative to the total number of cells. Apoptotic cells were quantified by collecting images of stained cells using Photoshop software (Adobe Systems, San Jose, CA).
Lentivirus Transfection
For lentivirus transfection, cDNA encoding Trp53 DD (D; gift from Dr. M. Oren, Weizmann Institute of Science), Pou5f1, Sox2, and Klf4 (gifts from Dr. S. Yamanaka, Kyoto University) were cloned into the CSII-EF1a-IRES2-Venus vector, whereas Myc (M; gift from Dr. H. Saya, Keio University) and Hras1V12 (R; gift from Dr. S. Yamanaka) were cloned into the CSII-EF1a-IRES2-humanized Kusabira Orange1 (hKO1) vector. Lentivirus particles were produced by transient transfection of 293T cells, and transfection was carried out as described previously [12] . The virus titer was determined by transfecting 293T cells, and the multiplicities of infection was adjusted to 1.0 for all experiments. Equal volumes of each virus supernatant were mixed for experiments using virus mixtures, and the total titer was determined. An empty lentivirus vector was used as a control. To quantify colony numbers, 1 3 10 5 cells were plated in a 12-well plate, and a colony was defined when the cells produced cell clusters that were larger than 0.1 mm at 6 days after transfection. Alkaline phosphatase staining was conducted using a VECTOR Alkaline Phosphatase Staining Substrate kit (Vector Lab, Burlingame, CA).
Flow Cytometry
The primary antibodies used were biotinylated mouse anti-mouse FUT4 (MC-480; eBioscience, San Diego, CA), rat anti-mouse EPCAM (G8.8, BioLegend), rat anti-human ITGA6 (GoH3; BioLegend), rat anti-mouse CD44 (KM114; BD Biosciences), rat anti-mouse PROM1 (13A4; eBioscience), and biotinylated rat anti-mouse KIT (2B8; eBioscience). The primary antibodies were detected by allophycocyanin (APC)-conjugated goat anti-rat IgG (BD Biosciences) or APC-conjugated streptavidin (eBioscience). Cells were analyzed on a FACSCalibur (BD Biosciences).
Transplantation Procedure
For transplantation, cultured cells were dissociated with trypsin, and approximately 10 6 cells were microinjected into the seminiferous tubules of KSN nude mice that had been treated with 44 mg/kg busulfan at 4 wk of age (Japan SLC) [10] . Within 5 days after busulfan treatment, these mice received a bone marrow transplant from syngeneic donors to prevent bone marrow failure. The animals were used for transplantation at least 4 wk after busulfan treatment. The injection was performed via an efferent duct [10] . Approximately 80-90% of the tubules were filled in each recipient testis. For subcutaneous transplantation, approximately 2-4 3 10 6 cells were transplanted. In both experiments, the recipient mice were killed between 4 and 6 wk after transplantation. The Institutional Animal Care and Use Committee of Kyoto University approved all the animal experimentation protocols.
Histology and Immunohistochemistry
Tissue samples were fixed in 10% neutral-buffered formalin for overnight and embedded in paraffin blocks for sectioning. All sections were stained with hematoxylin and eosin. For immunohistochemistry, tissue samples were fixed in 4% paraformaldehyde for 2 h, embedded in Tissue-Tek OCT compound, and processed for cryosectioning. The primary antibodies used were mouse antihuman TNFRSF8 (GeneTex, Irvine, CA), goat anti-mouse PDPN (R&D Systems), mouse anti-human MAGEA4 (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-human ALPP (Santa Cruz Biotechnology), rabbit antimouse NANOG (ReproCELL, Tokyo, Japan), and rabbit anti-human CHGA (Abcam, Cambridge, U.K.). The primary antibodies were detected by Alexa Fluor 568-conjugated goat anti-rabbit IgG, Alexa Fluor 488-conjugated goat anti-mouse IgG, or Alexa Fluor 555-conjugated donkey anti-goat IgG (Invitrogen). Hoechst 33342 (Sigma) was used for counterstaining. Cells expressing GCT markers were determined by quantifying the signal intensities of pixels of tumors in random visual fields from five slides using Photoshop software (Adobe Systems).
RT-PCR
Total RNA was isolated using Trizol reagent (Invitrogen). First-strand cDNA was produced using Superscript II (RNase H À Reverse Transcriptase, both from Invitrogen). The PCR conditions were 948C for 5 min, 30 cycles at 948C for 1 min, 608C for 1 min, and 728C for 1 min, followed by 728C for 10 min. The primers used for PCR were Nanog: 
Western Blot Analysis
We used SDS-PAGE to separate cell lysates, which were transferred to Hybond-P membranes (Amersham Biosciences, Little Chalfont, Buckinghamshire, U.K.). The primary antibodies used were rabbit anti-human ZBTB16, goat anti-human POU5F1 (both from Santa Cruz Biotechnology), rabbit antihuman DDX4 (Abcam), rabbit anti-mouse NANOG (ReproCELL), and mouse anti-mouse NEUROG3 (BD Biosciences). The primary antibodies were detected by horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG, HRP-conjugated horse anti-mouse IgG (both from Cell Signaling Technology, Danvers, MA), or HRP-conjugated chicken anti-goat IgG (Santa Cruz Biotechnology). Immunoreactive bands were visualized with the ECL Plus Western blotting detection system (Amersham Biosciences).
Combined Bisulfite Restriction Analysis
Genomic DNA was treated with sodium bisulfite, which deaminates unmethylated cytosines to uracils. Using this template, differentially methylated regions of the indicated genes were amplified by PCR. PCR primers used were Pou5f1-distal-1: 
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Karyotype Analysis
The cultured cells were incubated with colcemid solution (60 ng/ml; KaryoMAX, Invitrogen) for 1 h, recovered by trypsin, and treated with 75 mM KCl for 7 min. Metaphase spreads were prepared by a standard method after fixing the cells with methanol/acetic acid (3:1). The slides were stained with Hoechst 33258 (Sigma).
Statistical Analysis
Results are presented as mean 6 SEM. Data were analyzed using the Student t-test. Results of immunohistochemistry and transformation frequency after EPCAM or CD9 selection were analyzed using analysis of variance followed by Tukey HSD.
RESULTS
Transformation of Testis Cells by Cotransfection of Three Oncogenes
In our preliminary experiments, we examined the impact of dominant negative Trp53 (Trp53 DD; D) and Myc (M) cDNAs on GS cell transformation. Together with Hras1V12 (R), this set of oncogenes transforms a variety of somatic cells in vitro [13] . We constructed lentiviruses that express D, M, and R genes and transfected GS cells with different combinations of these three viruses. While no apparent changes were observed after transfecting the D and R genes, transfection of the M gene induced rapid apoptosis of GS cells (Fig. 1, A and B). When the three genes were cotransfected, transfected GS cells continued to proliferate without cytokines but did not show any signs of transformation (Supplemental Figure S1 ; all supplemental data are available online at www.biolreprod.org).
Because of the potential difference between GS cells and SSCs in vivo [14] , we hypothesized that freshly isolated SSCs are more susceptible to viral transfection and could be transformed in vitro. Spermatogonia from pup testes, which are relatively enriched for SSCs because of the absence of spermatids and spermatozoa [15] , were collected by taking advantage of CD9, a SSC marker [16] . MACS-selected cells were transfected, and transformation was monitored by the appearance of foci of rapidly growing cells (Fig. 1C) . Although a single transfection of the D or R genes did not show an apparent effect, transfection of the M gene caused apoptosis of CD9-expressing cells (Fig. 1, A and B) . Cotransfection of the MR or DM genes produced small colonies, but they could not be propagated after one or two passages, suggesting that they were not fully transformed. In contrast, when DMR genes were cotransfected, spermatogonia changed their morphology and began to proliferate actively, and colonies with diverse morphology were found. Some of the colonies lacked apparent cell borders and resembled embryonic stem (ES) cells, but others resembled GS cell colonies. Transformed cells could be maintained in ES cell culture medium without GDNF. Moreover, while GS cells grew only on MEFs, transformed cells could grow in methylcellulose (Fig. 1D ), indicating that they could grow in an anchorage-independent manner. Unlike GS cells, some of the colonies were strongly positive for alkaline phosphatase (Fig 1E) .
Transfection of Yamanaka Factors Produced ES-Like Cells from CD9-Selected Cells
The close resemblance of some of the DMR-transfected cells to ES cells suggested that transformed cells acquired a phenotype similar to ES cells. The recent development of iPS technology allows for the generation of ES-like cells from somatic cells by transfecting the Klf4, Myc, Sox2, and Pou5f1 (KMSO) genes [17] . Therefore, we expected that transfection of the four genes into GS cells or freshly isolated CD9-selected cells would produce ES-like cells. We transfected both GS cells and CD9-selected cells with lentivirus vectors that express the KMSO genes. Although KMSO gene upregulation was thought to be responsible for spontaneous conversion of GS cells into ES-like mGS cells [9, 18] , only CD9-selected cells and not GS cells produced ES-like cells on KMSO transfection (Fig. 1C) . Colony formation started as soon as 6 days after transfection, and fully established colonies were found by 3 wk. Interestingly, unlike DMR transfection, we were unable to obtain colonies with GS-like morphology in the KMSO gene transfection. The KMSO-transfected cells closely resembled those produced from MEFs and were maintained in ES cell culture medium. KMSO-transfected cells also proliferated in methylcellulose, but they generally formed smaller colonies compared with those in DMR-transfected cells (Fig. 1D) . The frequency of colony development was significantly higher for KMSO transfection than for DMR transfection (Fig. 1F) .
Identification of Target Cell Population
The number of colonies decreased significantly when CD9 þ cells were removed by MACS before transfection ( Fig. 2A) . Although this result suggested that transformation occurred by SSC transduction, several types of cells, including somatic cells, express CD9 in the testis [19] , and it was possible that somatic cells can transform more easily than SSCs. Therefore, we carried out two sets of experiments to examine the origin of the transformed cells. In the first set of experiments, we used W mice, which are infertile because of the almost total absence of germ cells due to mutations in the KIT receptor tyrosine kinase [15] . After MACS selection and lentivirus transfection of W testis cells, the number of colonies decreased significantly compared with those generated from WT mice (Fig. 2B) , which suggested that both DMR and KMSO genes transformed germ cells. In the second set of experiments, we used anti-EPCAM antibody to examine the stage of target germ cells. We recently showed that EPCAM-selected spermatogonia express KIT and have little SSC activity, while CD9-selected cells show little KIT expression and have higher levels of SSC activity [19] . In contrast to the CD9-selected cells, few colonies developed after transduction of EPCAM-selected cells by DMR or KMSO genes (Fig. 2C) . These results suggested that spermatogonia with little or no KIT expression are the major target of the transformed cells.
Phenotypes of DMR-or KMSO-Transfected Clones
To examine the difference between DMR-and KMSOtransfected cells, clones of transformed colonies were picked 6-18 days after transfection and subsequently expanded on MEFs. When clones were picked from DMR-transfected cells, .80% expanded successfully. In contrast, ;30% of KMSOtransfected clones were derived by the same procedure, suggesting that DMR-transfected cells underwent more efficient self-renewal division. The established clones were passaged every 2-3 days. The clonal origin was confirmed by Southern blotting using virus-specific probes (Supplemental Figure S2) .
We used RT-PCR to characterize these cells (Fig. 3A) . The expression levels of spermatogonia markers (Ddx4, Zbtb16, Taf4b, and Neurog3), ES cell markers (Nanog and Tdgf1), and a common marker (Pou5f1) were examined. Although all the DMR-transfected clones expressed Taf4b and some retained Zbtb16, they completely lacked Pou5f1 or Ddx4 expression, TESTIS CELL TRANSFORMATION suggesting that DMR-transfected cells no longer have a spermatogonia phenotype. Although Tdgf1 was weakly expressed, none of the DMR clones expressed Nanog, which is an essential pluripotency marker. In contrast, Tdgf1 was more strongly expressed in KMSO-transfected cells, and Nanog was expressed in at least four of the KMSO-transfected clones, suggesting that they underwent reprogramming to an ES cell-like state. However, not all the Nanog-expressing cells were completely reprogrammed because one of these Nanogexpressing clones clearly expressed Neurog3. Western blot analyses confirmed the expression of NANOG and POU5F1 in KMSO-transfected cells, but we could not detect spermatogonia markers, such as DDX4, ZBTB16, and NEUROG3, in transfected cells (Fig. 3B) . 
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To functionally characterize these cells, we chose three independent clones from DMR-transfected cells based on their morphology and results of gene expression analyses (Fig. 3, A-C) . DMR clones 1 and 5 resembled GS and ES cells, respectively. DMR clone 6 consisted of colonies that appeared to be a mixture of GS and ES cells. In addition, we analyzed three clones from the KMSO-transfected cells, two Nanogexpressing clones (clones 3 and 4), and a Nanog-negative clone (clone 7). All these KMSO clones were indistinguishable from each other and resembled ES cells. Although both DMR and KMSO clones proliferated at comparable speed on MEFs (Fig. 4A) , KMSO-transfected cells did not attach well to laminin-coated plates but proliferated more efficiently on gelatin (Fig. 4B) . In contrast, DMR-transfected cells attached preferentially to laminin-coated plates and did not adhere to gelatin-coated plates. Compared with DMR or KMSO clones, MEF-derived iPS cells generally showed poor attachment regardless of substrate.
Variation in the cell phenotype was also evident by flow cytometric analyses (Fig. 4C) . Overall, DMR-transfected cells lacked KIT, FUT4, and PROM1 expression. DMR clone 6 lacked expression of EPCAM, a surface marker for ES cells and spermatogonia. In contrast, KMSO-transfected cells expressed these molecules, except KMSO clone 7, which did not express Nanog and also did not express FUT4. The surface marker expression patterns were different from those of ES and mGS cells in that they lacked expression of CD44, a cancer stem cell antigen [20] . We also observed expression of CD44 in MEF-derived iPS cells. To examine whether they retained a normal chromosome number, we conducted a karyotype analysis. Two DMR clones contained euploid cells at low levels (3.1%-21.6%), whereas the other had no euploid cells. The average chromosome number was 44-73. In contrast, the average chromosome number of the three KMSO clones was 40, and euploid cells made up 44%-81% of analyzed cells (Fig. 4D) .
DNA Methylation Patterns in DMR-and KMSO-Transfected Clones
To examine whether the transfected cells retain normal DNA methylation patterns, we used combined bisulfite restriction analysis (COBRA). We first examined the regulation of Pou5f1, which was no longer expressed in DMRtransfected cells. This gene has distal and proximal enhancers (DE and PE) in the 5 0 -flanking region (Fig. 5A) . The former drives Pou5f1 expression in preimplantation embryos, primordial germ cells (PGCs), and ES/embryonic germ cells [21] . The latter drives expression in the epiblast. While HpyCH4 IV site (À4408) in DE of GS cells was sensitive to enzymatic TESTIS CELL TRANSFORMATION digestion, digestion was relatively poor in mGS cells. HpyCH4 IV site in DMR-and KMSO-transfected cells were not methylated, and the methylation levels at two Taq I sites (À3037 and À2830) in DE was comparable to those in GS or mGS cells. However, Taq I site (À314) in PE of DMRtransfected cells was significantly more sensitive to restriction enzyme digestion, which agrees with the loss of Pou5f1 expression by RT-PCR analysis. In addition, one of the KMSO clones that did not express Nanog also showed high methylation in Taq I site in PE compared with the other two Nanog-expressing clones.
We then examined the methylation levels of differentially methylated regions of the imprinted genes (Fig. 5B) . Male germ cells in the postnatal testis, including WT and Ras-GS cells, exhibit androgenetic methylation patterns in differentially methylated regions of imprinted genes, including hypermethylation of H19 and Meg3 differentially methylated regions, and hypomethylation of Igf2r and Peg10 differentially methylated regions [22] . COBRA analyses showed that H19 and Meg3 underwent demethylation in both DMR-and KMSO-transfected clones. In contrast, all the DMR-and KMSO-transfected clones exhibited increases in methylation of both Igf2r and Peg10. Analyses of the remaining clones also showed a similar methylation pattern. Strikingly, one of the MEF-derived iPS cell clones showed demethylation in Meg3, but we did not observe significant changes in other imprinted genes.
Generation of Tumors after Transplantation
In the final set of experiments, we transplanted both DMR and KMSO clones into an in vivo environment to examine their developmental potential (Fig. 6A) . We chose DMR clone 1 (GS-like), DMR clone 5 (ES-like), KMSO clone 3 (Nanog þ ), and KMSO clone 7 (Nanog À ) and compared their tumorigenic activity. We also transplanted MEF-derived iPS cells. Cells were microinjected into the seminiferous tubules of infertile mouse testes. The same cell populations were also injected subcutaneously to examine the effect of the host environment. All the recipients developed tumors within 4 wk after transplantation regardless of the site of transplantation.
Despite differences in gene expression patterns, histological analyses revealed that both DMR-and KMSO-transfected cells produced mixed GCTs regardless of the transplantation site (Fig. 6B) . We also found similar histology after transplantation of MEF-derived iPS cells. Some areas showed teratomatous components and preferentially differentiated into a neuroendocrine lineage, which was confirmed by CHGA expression (Fig.  6C) . Neural tube-like structures were observed in all tumor types (Fig. 6B) . However, we found other areas that expressed PDPN or MAGEA4, both of which are seminoma markers. Tumors also contained embryonal carcinomas because they expressed TNFRSF8, an embryonal carcinoma marker. ALPP, which is expressed in both seminoma and embryonal carcinomas, were also detected (Fig. 6C) . Quantitative assessment of markers showed that PDPN is more widely expressed in tumors from DMR-transfected cells (Fig. 6D) . We found no evidence of spermatogenesis despite injecting into the seminiferous tubules. This was in contrast to Ras-GS cells that reinitiated spermatogenesis after transplantation [8] .
RT-PCR analyses of the subcutaneous tumors showed that some of the tumors continued to express spermatogonial markers, such as Neurog3 (Fig. 6E) . However, we also found Nanog expression in tumors developed from both DMR-and KMSO-transfected cells, which suggested a reactivation of pluripotent genes in vivo. Consistent with this observation, clusters of NANOG-expressing cells were present in tumors developed from DMR-transfected cells by immunohistochemistry (Fig. 6C) . Although we did not find statistical significance, NANOG distributed more widely in tumors from DMRtransfected cells (Fig. 6D) .
COBRA was used to examine changes in DNA methylation patterns after transplantation. While H19 demethylation and Igf2r methylation were maintained in tumors developed from DMR clones, KMSO clone 3 showed slight demethylation in Igf2r (Fig. 6F) , suggesting that DNA methylation pattern was not necessarily consistent with the original clones. H19 and Igf2r mRNA expression was confirmed by RT-PCR (Fig. 6G) .
DISCUSSION
The collaboration of several oncogenes is generally required to transform primary somatic cells. However, very little is known about the mechanism of GCT formation. Although some candidate genes are discovered from human GCT studies [1, 2] , a lack of an in vitro transformation system has made it difficult to study the mechanism of this process. Ideally, a pure population of SSCs would be useful for such studies because they proliferate indefinitely and can be genetically manipulated. Unfortunately, however, because SSC-specific markers have not been identified, it is impossible to distinguish them from committed 
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progenitors or somatic cells by currently available methods. In this study, we took advantage of CD9 expression on SSCs, allowing us to collect an enriched population of SSCs. Although this molecule is also expressed on committed progenitors and somatic cells, tumors expressing GCT markers were successfully generated following lentivirus-mediated oncogene transfer into CD9-expressing testis cells. Therefore, this system provides a new method to study GCT formation in vitro.
We previously reported that lentivirus-mediated transfection of Hras1V12 or cotransfection of Ccnd2 and Ccne1 into GS cells induces seminomatous tumors. Although these tumors were reminiscent of those developed in GDNF transgenic mice, they developed only after transfected cells were transplanted into the seminiferous tubules [8] . In fact, it is still under debate whether the GDNF-induced tumors in mice resemble more spermatocytic seminomas in humans, in which Hras1 mutations can be found [23, 24] . To set up an in vitro system for GCTs generation, several genes were transfected using lentivirus vectors, which showed efficient transduction of GS cells [8] . Mixed GCTs were formed when either DMR or KMSO genes were cotransfected into CD9-expressing testis cells. DMR genes are commonly used to transform primary somatic cells [13] . Similar tumors were also produced when KMSO genes, which can ''reprogram'' somatic cells into pluripotent stem cells, were transfected. These colonies were most likely developed from SSCs or undifferentiated spermatogonia because the number of colonies was consistently fewer when we transfected W testes or EPCAM-expressing cells that were reduced in SSC concentrations. These results suggest that germ cells are vulnerable to the same transformation protocol as somatic cells.
One of the important observations after DMR transformation was the dramatic changes in cell phenotype. The transfected clones showed wide variations in their colony morphology and marker expression. In addition, because some of the clones resembled ES cells, we initially thought that they had become pluripotent. Although they lost expression of several spermatogonial markers, such as Ddx4 or Zbtb16, all the clones did not express Pou5f1, which is expressed not only in ES cells but also in iPS cells [17] . Moreover, they lacked Nanog, a critical regulator of pluripotency. These results suggested that DMR transfection does not induce bona fide pluripotent cells. Similarly, although KMSO clones resembled ES cells and some expressed Nanog, even these cells retained the spermatogonial markers and expressed CD44, which is not expressed in ES cells [25] . CD44 is expressed in both seminomas and nonseminomas, including teratomas or seminomas from Ras-GS cells [8, 26] . Therefore, the transformed cells only partially resembled ES cells or GCTs before transplantation.
In addition to the phenotypic differences, we noted that DMR-transfected cells had abnormal karyotypes, while the majority of KMSO-transfected cells remained euploid. This was in contrast to Ras-GS cells, which retained normal chromosome number and reinitiated spermatogenesis after culture [8] . Although we currently do not know how the karyotype abnormality was caused by transfection, it is likely that Trp53 inhibition may have played a primary role, as Trp53 is involved in chromosome stability [27] . This notion is supported by the recent observation that producing iPS cells by Trp53 inhibition leads to severe karyotype abnormalities [28] . It also should be noted here that human GCTs are characterized by peri-triploid DNA content, which is similarly found in GDNF-induced tumors [23] . However, the mechanism of triploidization is not known. Because we did not check the ploidity of the tumors in the current study, we do not know the impact of the transgenes in vivo on triploidization. However, generation of GCTs with seminoma markers from diploid KMSO-transfected cells suggests that ploidity may not necessarily influence tumor marker expression. In this context, analyses of GCTs in this study may be useful because it may provide a clue to understand the relationship between karyotype changes and tumor phenotype.
Despite the difference in karyotype, DMR-and KMSOtransfected cells underwent demethylation in H19 and Meg3 genes and methylation in Igf2r and Peg10 genes. Although Ras-GS cells did not show such abnormal DNA methylation, we previously noted a similar change when GS cells were converted into mGS cells [9] . These results suggest that conversion into pluripotent cells and testis cell transformation are accompanied by similar epigenetic changes in imprinted genes. Interestingly, we also found aberrant DNA methylation in Meg3 in one of the MEF-derived iPS clones, suggesting that other imprinted genes are also affected during reprogramming. GCTs generally show low levels of H19 methylation, and their level of expression is dependent on the differentiation lineage and maturation stage [29] . While spermatocytic seminomas show H19 hypermethylation and complete demethylation of Igf2r, seminomas and nonseminomas show biallelic expression of the H19 gene [30] . Interestingly, biallelic expression of H19 continues even in well-differentiated tissues [30] .
It is generally accepted that human GCTs are representative of PGCs from which they originate [29] , as these epigenetic changes are reminiscent of those found in PGCs. This is clearly demonstrated by patients with various forms of disorders of sex development. Although we cannot totally exclude the possibility that differences in DNA methylation patterns influenced growth rate and led to selection of biased cell type, our results suggest that dynamic changes in DNA methylation can occur after transformation, which raises the possibility that some GCTs may develop from postnatal germ cells and that they undergo H19 demethylation as a result of transformation. The mechanism of GCT development may differ between species, as we did not observe Pou5f1 expression in our transfected cells, which is observed in all cases of human GCTs [31] . Such distinct phenotype of GCTs may be caused, in part, by the difference in the gene expression patterns in PGCs. For example, while Sox2 is not expressed in human PGCs, it is expressed in mouse PGCs [32] . Despite its absence, many Sox2 target genes are expressed in human PGCs [33] , and such difference in Sox2 or other pluripotency-associated genes may contribute to the different mode and onset of GCT production. Nevertheless, very little is known about the difference between mouse and human germ cells, and the possibility of postnatal GCT origin needs to be evaluated in future experiments.
The transplantation experiments revealed that the type of transfected gene has little impact on differentiation patterns. We speculate that the discrepancy between molecular characteristics in vitro and their GCT morphology in vivo may be caused by hypoxia in tumors. It is known that oxygen pressure in solid tumors is generally lower and that this causes heterogeneity of tumor tissues and dedifferentiation in some cases [34] . Interestingly, unlike ES cells, DMR-and KMSO-transfected cells did not differentiate into mature teratomas. We instead found mixed GCTs that contained predominantly neuroendocrine tissues. Biased differentiation is known to occur in testicular teratomas, and neural tissues are found in virtually all cases of spontaneous teratomas in mice [35] . However, this biased differentiation does not appear to reflect their germ cell origin because we observed TESTIS CELL TRANSFORMATION similar tumors after transplanting MEF-derived iPS cells. This is in contrast to results with iPS cells produced by retrovirus or lentivirus with inducible promoters. As previously pointed out, histology of iPS-derived tumors is influenced by the promoter in the virus [36] . Viral promoters are generally suppressed in iPS/ES cells, which allow for their differentiation by suppressing the expression of exogenous reprogramming factor [17] . However, constitutive strong expression of transgenes by the internal elongation factor promoter may have limited differentiation into diverse tissue types in our study. It will be important to test other promoters to examine whether they can influence the developmental potential of these transfectants.
Another unexpected observation was that GCT formation was successful only with freshly isolated testis cells but not with GS cells. We originally used GS cells because Ras-GS cells transformed into seminomatous tumors in vivo [8] . In addition, GS cells convert into mGS cells, which can produce teratomas. Therefore, we had good reason to believe that they would provide an attractive target for GCT studies. There are at least two possibilities. One is that SSCs may be comprised of different subclasses. SSCs are functionally defined by their ability to produce germ cell colonies in vivo, but some SSCs may have more primitive or undifferentiated characteristics. GS cells may have been derived from a particular subclass of SSCs that are resistant to oncogenic insults. Alternatively, GS cells may have undergone aging after repeated in vitro passages and become more resistant to transformation. Because we cannot completely exclude the possibility that committed spermatogonia progenitors or somatic cells converted into tumors with GCT markers, further investigation of this issue is also important in future studies.
A number of genes exhibit abnormal expression in human GCTs, but the lack of an assay system for in vitro transformation prevented detailed functional analyses. Generating a variety of GCT tumors from in vitro dissociated testis cells will be a useful strategy to understand GCT pathogenesis. Candidate genes can now be routinely tested using a similar approach. Very little is known about the relationship between different types of GCTs, including the origin and sequence of events that leads to GCTs with variable characteristics. The development of an in vitro transformation assay will also be useful for understanding the mechanism of reprogramming and its relationship with GCTs.
